The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide ...

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...

Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic ...

13 in the journal JAMA Network Open. By comparison, Saxenda (liraglutide) prompted similar weight loss in only 29% of those being treated for obesity and 12% being treated for type 2 diabetes.

The weight-loss drug liraglutide helped obese children ... are the first to demonstrate the effects of liraglutide (Saxenda) on children ages 6 to 11. "The results of this study offer considerable ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

In a much-anticipated release, the Congressional Budget Office (CBO) published projections estimating it would cost Medicare ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

Weight-loss injections have revolutionized obesity treatment in adults, and now, their effectiveness has been proven in children. A new study revealed that the injection "Saxenda" led to significant ...